Levels and localization of group II phospholipase A2 and annexin I in interleukin- and dexamethasone-treated rat mesangial cells: evidence against annexin mediation of the dexamethasone-induced inhibition of group II phospholipases A2-Reference-Cited by-同舟云学术

Levels and localization of group II phospholipase A2 and annexin I in interleukin- and dexamethasone-treated rat mesangial cells: evidence against annexin mediation of the dexamethasone-induced inhibition of group II phospholipases A2

Published:1994-12 Issue:3 Volume:1224 Page:541-550
ISSN:0167-4889
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Cell Research

Author:

Vervoordeldonk Margriet J.B.M.,Schalkwijk Casper G.,Vishwanath Bannikuppe S.,Aarsman Anton J.,van den Bosch Henk

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference63 articles.

1. Interleukin-1β, tumor necrosis factor and forskolin stimulate the synthesis and secretion of group II phospholipase A2 in rat mesangial cells

2. Cytokine-and forskolin-induced synthesis of group II phospholipase A2 and prostaglandin E2 in rat mesangial cells is prevented by dexamethasone

3. The Annexins and Exocytosis

4. Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins

5. Five distinct calcium and phospholipid binding proteins share homology with lipocortin I.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renal Expression of Annexin A1 Is Associated With the Severity of Renal Injury in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis;Frontiers in Medicine;2022-06-17

2. Therapeutic Potential of Annexin A1 Modulation in Kidney and Cardiovascular Disorders;Cells;2021-12-05

3. Anaphylactic shock with methylprednisolone, Kounis syndrome and hypersensitivity to corticosteroids: a clinical paradox;Italian Journal of Pediatrics;2018-11-28

4. Exploiting the Annexin A1 pathway for the development of novel anti-inflammatory therapeutics;British Journal of Pharmacology;2009-10

5. Henk van den Bosch: chemist and biochemist;Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids;2004-03